Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, Status and Forecast 2020-2026
Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
Market Analysis and Insights: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
In 2019, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was US$ 9621.4 million and it is expected to reach US$ 37920 million by the end of 2026, with a CAGR of 21.4% during 2021-2026.
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Scope and Market Size
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented into CellSearch, Others, etc.
Segment by Application, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented into Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Other Cancers Diagnosis and Treatment, etc.
Regional and Country-level Analysis
The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) business, the date to enter into the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) product introduction, recent developments, etc.
The major vendors include Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, etc.
This report focuses on the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
CellSearch
Others
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
Market Analysis and Insights: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
In 2019, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was US$ 9621.4 million and it is expected to reach US$ 37920 million by the end of 2026, with a CAGR of 21.4% during 2021-2026.
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Scope and Market Size
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented into CellSearch, Others, etc.
Segment by Application, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented into Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Other Cancers Diagnosis and Treatment, etc.
Regional and Country-level Analysis
The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share AnalysisCirculating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) business, the date to enter into the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) product introduction, recent developments, etc.
The major vendors include Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, etc.
This report focuses on the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
Market segment by Type, the product can be split into
CellSearch
Others
Market segment by Application, split into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
